Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies

The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

pharmacology
Vaccines Without Vials, Fridges, or Needles
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Amy Schleunes | Apr 7, 2020
Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Ruth Williams | Dec 11, 2019
A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.
Cancer Drugs in Development May Be Targeting Wrong Proteins
Cancer Drugs in Development May Be Targeting Wrong Proteins
Shawna Williams | Sep 12, 2019
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Image of the Day: Right on Target
Image of the Day: Right on Target
Nicoletta Lanese | Jul 23, 2019
An injectable biomaterial calls cancer drugs to tumor sites in mice.
How the Brain Changes on Ketamine: A Live Animal Study
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Researchers Getting Smarter About Pairing Cancer Treatments
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
Infographic: Cancer Drug Pairings
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
Jim Daley | Feb 7, 2018
The Scientist speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.
Nasser Zawia: An American Scientist Born in Yemen
Nasser Zawia: An American Scientist Born in Yemen
Bob Grant | Mar 23, 2017
The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s. 
Mystery Mechanisms
Mystery Mechanisms
Tanya Lewis | Jul 29, 2016
Scientists still don’t know exactly how some commonly used drugs work. Here’s a look at three such compounds.
Antibiotic Assistants
Antibiotic Assistants
Ruth Williams | Mar 9, 2016
Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.  
Hearing Help
Hearing Help
Kate Yandell | Sep 1, 2015
For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
 
Light-Operated Drugs
Light-Operated Drugs
Ruth Williams | Nov 1, 2014
Scientists create a photosensitive pharmaceutical to target a glutamate receptor.
Elder Pharmacology
Elder Pharmacology
Nir Barzilai | Jan 1, 2014
Studying and treating the chronic diseases associated with aging needs serious revamping.
Celebrated Neuroscientist Dies
Celebrated Neuroscientist Dies
Kate Yandell | Sep 23, 2013
Candace Pert, who helped discover opioid receptors, has passed away at age 67.